HARDING THOMAS C. (See Remarks) sold 0.2% of their position (6.00 shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $7.74 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/4/2022ACC: 0000899243-22-032655
Officer· See Remarks
Since Dec 2020
-6.00
Net shares
Net seller
$7.74
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.00 acquired · 21.00 disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+15.00
Price / share
—
Trade value
—
% of position
0.4%
10/1/2022
3.67K→3.69K
Common Stock
Indirect
Shares
−6.00
Price / share
$1.29
Trade value
$7.74
% of position
0.2%
10/3/2022
3.69K→3.68K
Total
Net shares
+9.00
Net value
-$7.74
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/1/2022 | M · Option Exercise | +15.00 | — | — | 0.4% | 3.67K | 3.69K |
| Common Stock Indirect | 10/3/2022 | S · Sale | −6.00 | $1.29 | $7.74 | 0.2% | 3.69K | 3.68K |
| Total | +9.00 | -$7.74 | ||||||
Derivative Transactions1
Restricted Stock Units
Indirect
Converts to
Common Stock
15.00 shares
Shares
−15.00
Strike price
Held after
109.00
Exercisable
—
10/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Indirect | Common Stock15.00 shares | 10/1/2022 | M · Option Exercise | −15.00 | — | 109.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned17.82K
Total
17.82K direct17.82K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.82K | Direct |
| Total | 17.82K | 17.82K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported